The Drug Discovery and Pharmacology team at BenevolentAI leverages advanced AI and machine learning technologies to enhance the understanding of complex disease mechanisms and identify novel therapeutic targets. This team is instrumental in progressing over 25 drug programs through the stages of discovery and early development, aiming to bring life-changing medications from concept to clinical practice. They collaborate closely with both internal and external partners to ensure that scientifically robust and clinically validated drugs reach patients in need.
View all